deferiprone has been researched along with Cerebellar Ataxia in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Cerebellar Ataxia: Incoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifteen postoperative patients with superficial siderosis were recruited, and seven patients were administered deferiprone (combination therapy group)." | 4.12 | Quantitative clinical and radiological recovery in post-operative patients with superficial siderosis by an iron chelator. ( Nose, Y; Sanjo, N; Sasaki, M; Tateishi, U; Uwano, I; Yokota, T, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nose, Y | 1 |
| Uwano, I | 1 |
| Tateishi, U | 1 |
| Sasaki, M | 1 |
| Yokota, T | 1 |
| Sanjo, N | 1 |
| Parakh, N | 1 |
| Sharma, R | 1 |
| Prakash, O | 1 |
| Mahto, D | 1 |
| Dhingra, B | 1 |
| Sharma, S | 1 |
| Chandra, J | 1 |
2 other studies available for deferiprone and Cerebellar Ataxia
| Article | Year |
|---|---|
Quantitative clinical and radiological recovery in post-operative patients with superficial siderosis by an iron chelator.
Topics: Cerebellar Ataxia; Deferiprone; Humans; Iron Chelating Agents; Magnetic Resonance Imaging; Neurodege | 2022 |
Neurological Complications and Cataract in a Child With Thalassemia Major Treated With Deferiprone.
Topics: beta-Thalassemia; Cataract; Cerebellar Ataxia; Child; Deferiprone; Humans; Iron Chelating Agents; Ma | 2015 |